- Biological therapy for lupus nephritis-tribulations and trialsRona M Smith
Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB2 0QQ, UK
Nat Rev Rheumatol 6:547-52. 2010..The complexities of clinical trials in lupus nephritis have impeded the demonstration of the efficacy of new agents, but if these difficulties can be overcome, there is a real chance that outcomes in lupus nephritis will improve...
- Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitisRona M Smith
Addenbrooke s Hospital, Cambridge, UK
Arthritis Rheum 64:3760-9. 2012..However, further relapse is common, and maintenance strategies are required. The aim of this study was to reduce relapse rates using a fixed-interval rituximab re-treatment protocol...
- Progress in treatment of ANCA-associated vasculitisRona M Smith
Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB20QQ, UK
Arthritis Res Ther 14:210. 2012..As rare diseases, treatment advances in vasculitis depend on international collaborative research networks both to establish an evidence base for newer agents and to develop recommendations for patient management...